5 news items
Exact Sciences Says It Demonstrates Continued Leadership In Early Cancer Diagnosis And Improved Health Outcomes For Patients With Multiple Data Presentations At American Society Of Clinical Oncology Annual Meeting
EXAS
24 May 24
test in racially and ethnically diverse patients. Exact Sciences will also present data on its approach to multi-cancer early detection (MCED) across
Exact Sciences Demonstrates Continued Leadership in Early Cancer Diagnosis and Improved Health Outcomes for Patients with Multiple Data Presentations at ASCO®
EXAS
24 May 24
Score® test in racially and ethnically diverse patients. Exact Sciences will also present data on its approach to multi-cancer early
Exact Sciences To Present Late-Breaking Data From ASCEND-2 Study Validating Its Investigational Multi-Cancer Early Detection Test At AACR Annual Meeting 2024
EXAS
8 Apr 24
11,000 clinically characterized participants from a racially, ethnically, and geographically diverse cohort representative of the U.S. population
Exact Sciences to Present Late-Breaking Data from ASCEND-2 Study Validating Its Investigational Multi-Cancer Early Detection Test at AACR Annual Meeting 2024
EXAS
8 Apr 24
clinically characterized participants from a racially, ethnically, and geographically diverse cohort representative of the U.S. population. These data
The New England Journal of Medicine Publishes Cologuard Plus™ Test Results from Pivotal BLUE-C Study
EXAS
13 Mar 24
-C study included 98 colorectal cancers and reflects racial and ethnic diversity of U.S
- Prev
- 1
- Next